MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

12 Aug 2025 Evaluate
The company witnessed a 12.31% growth in the revenue at Rs. 940.46 millions for the quarter ended June 2025 as compared to Rs. 837.36 millions during the year-ago period.Profit after tax for the quarter ended June 2025 reported a huge growth of 80.07% to Rs. 83.10  millions from Rs. 46.15 millions.Operating profit for the quarter ended June 2025 rose to 128.75 millions as compared to 80.00 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 940.46 837.36 12.31 940.46 837.36 12.31 4518.16 4212.30 7.26
Other Income 44.27 44.52 -0.56 44.27 44.52 -0.56 176.79 163.48 8.14
PBIDT 128.75 80.00 60.94 128.75 80.00 60.94 758.80 681.59 11.33
Interest 0.52 0.65 -20.00 0.52 0.65 -20.00 2.19 1.57 39.49
PBDT 128.23 79.35 61.60 128.23 79.35 61.60 756.61 680.02 11.26
Depreciation 15.31 15.87 -3.53 15.31 15.87 -3.53 65.26 60.57 7.74
PBT 112.92 63.48 77.88 112.92 63.48 77.88 691.35 619.45 11.61
TAX 29.82 17.33 72.07 29.82 17.33 72.07 182.99 169.73 7.81
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 83.10 46.15 80.07 83.10 46.15 80.07 508.36 449.72 13.04
Equity 28.91 28.91 0.00 28.91 28.91 0.00 28.91 28.91 0.00
PBIDTM(%) 13.69 9.55 43.29 13.69 9.55 43.29 16.79 16.18 3.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..